US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Stem Cell Market Research Reports & Industry Analysis

Stem cells are unique in that they are undifferentiated cells that can differentiate to become virtually any type of cell in the body (totipotent). They therefore represent an ongoing source of the specialized cells that make up the tissues and organs. There is great interest in stem cells because they have potential to replace defective or damaged cells resulting from a variety of disorders and injuries, leading to a range of new regenerative therapies.
Stem cells also have value as a research tool, as their in vitro study would allow scientists to learn more about the function of various organs and the development of particular diseases; stem cells may also eventually permit drug developers to test emerging therapies on diseased cells.

Cells must meet very specific criteria in order to be termed stem cells. They must: produce copies themselves; proliferate at a rapid rate; and display certain proteins on their surface that indicate a capacity to differentiate into other tissues, such as bone and cartilage. A stem cell line is a group of cells that all descend from a single original stem cell. Symmetric division gives rise to two identical daughter cells both endowed with stem cell properties. Asymmetric division produces only one stem cell and a progenitor cell with limited self-renewal potential.

RSS Feeds

Stem Cell Industry Research & Market Reports

< prev 1    3  4  
Stem Cell Therapeutics Markets
10/9/2014 | published by: Kalorama Information
... new regenerative therapies. Stem cells have become effective tools in blood diseases, musculoskeletal diseases, digestive disorders and many other areas. Kalorama Information’s Stem Cell Therapeutics Markets conducts in-depth research into the stem cell market opportunity ...  |  read more...
USD 3,995
Analysis of the Global Stem Cell Market
10/7/2014 | published by: Frost & Sullivan
... of??% from 2013 to 2018. The worldwide market for adult stem cell is estimated to be at $??billion in 2013 and is projected to reach $?? billion by 2018. Adult stem cells constitute ??% of ...  |  read more...
USD 6,000
Cell Isolation/Cell Separation Market by Product (Reagent, Media, Bead, centrifuge), Cell Type (human, stem cell, animal), Technique (Filtration, Surface Marker), Application (Research, IVD) & by End user (Hospital, Biotechnology) - Forecast to 2019
9/24/2014 | published by: MarketsandMarkets
... global cell isolation market is expected to reach $5.1 billion by 2019 from $2.5 billion in 2014, growing at a CAGR of 15.8% from 2014 to 2019. The global cell isolation market is categorized on ...  |  read more...
USD 4,650
Global and China Stem Cell Industry Report, 2014-2017
9/12/2014 | published by: Research in China
... be applied to treatment of cardiovascular diseases, leukemia (a kind of hematological system disease), nervous system diseases, damage or lesion of liver, kidney and other parenchymal organs, etc.. Currently, cord blood bank is the fastest-growing ...  |  read more...
USD 2,250
OpportunityAnalyzer: Graft-Versus-Host Disease - Opportunity Analysis and Forecasts to 2018
8/20/2014 | published by: GlobalData
... cell transplants and the increasing use of biologic off-label and marketed therapies in the 6MM. Sanofi is a key player in the GVHD market with Thymoglobuline and Lemtrada by infiltrating prophylaxis, aGVHD and cGVHD. J&J’s ...  |  read more...
USD 7,995
Stem Cells - Types, Technologies and Therapeutics
9/1/2014 | published by: RI Technologies
... are further classified into Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells and Other. Stem Cell Research by Technology is segmented into Stem Cell Transplantation, CB Genomics, Xenotransplantation, Cord Blood Banking and Other. ...  |  read more...
USD 8,100
Cell Therapy Deals and Alliances of 2013
8/1/2014 | published by: Current Partnering
... healthcare companies during 2013. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals ...  |  read more...
USD 1,495
The Global Market for Stem Cells
7/1/2014 | published by: BCC Research
... rate (CAGR) of 13.6% from 2013 through 2018. This report provides: An overview of the global market for stem cells and related technologies. Analyses of global market trends, with data from 2013, estimates for 2014, ...  |  read more...
USD 6,650
EpiCast Report: Graft-Versus-Host Disease - Epidemiology Forecast to 2023
7/1/2014 | published by: GlobalData
... attack the host’s cells as foreign. GVHD can progress from mild to severe forms as either acute GVHD (aGVHD) or chronic GVHD (cGVHD). Both aGVHD and cGVHD commonly affect organs such as the skin, gastrointestinal ...  |  read more...
USD 3,995
Regenerative Medicine Market in the US : 2014-2018
6/30/2014 | published by: TechNavio - Infiniti Research Ltd.
... Baxter International Inc., Johnson and Johnson Ltd., Kinetic Concepts Inc., Medtronic Inc., Stryker Corp., Aastrom Biosciences Inc., Acologix Inc., Advanced Cell Technology Inc., Arteriocyte Inc., Athersys Inc.,AvitaMedical Ltd., Bacterin International Inc., Bellicum Pharmaceuticals Inc., Bioactive ...  |  read more...
USD 3,000
Stem Cell Research Market in India 2014
6/20/2014 | published by: Netscribes (India) Pvt. Ltd.
... various benefits it offers. Stem cells can be used to cure a number of diseases, including cancer and neurological disorders such as Parkinson’s disease, among others. The number of parents opting for stem cell storage ...  |  read more...
USD 950
Hematopoietic Stem Cell Transplantation - Pipeline Review, H1 2014
4/30/2014 | published by: Global Markets Direct
... report provides comprehensive information on the therapeutic development for Hematopoietic Stem Cell Transplantation, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule ...  |  read more...
USD 2,000
Update: Stem Cells Pipeline Highlights – 2014
5/1/2014 | published by: Fore Pharma
... therapies for Stem Cells in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development ...  |  read more...
USD 720
Stem Cell Research Products - Opportunities, Tools, and Technologies
5/1/2014 | published by: BioInformant Worldwide, L.L.C.
... discovery, as the first mouse embryonic stem cells were derived from embryos in 1981, but it was not until 1995 that the first successful culturing of embryonic stem cells from non-human primates occurred and not ...  |  read more...
USD 3,495
Stem Cells - 6 Dimensional Assessment (Technical Insights)
6/27/2014 | published by: Frost & Sullivan
... potential to develop into many different cell types in the body during early life and growth. Indeed, under certain physiologic conditions they can be induced to become tissue or organ-specific cells with particular functions, thus ...  |  read more...
USD 6,500
Induced Pluripotent Stem Cells: Global Markets
6/1/2014 | published by: BCC Research
... market is expected to reach $2.9 billion in 2018, an estimated compound annual growth rate (CAGR) of 19.7% for the five-year period 2013 to 2018. This report provides: An overview of the global market for ...  |  read more...
USD 6,650
Cancer Stem Cells Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
... development and cancer drugs which are inhibitors of the Hedgehog, Notch, and WNT Pathway. These developmental pathways are frequently activated in neoplasms, and particularly in the rare subpopulation of cancer stem cells. There are today ...  |  read more...
USD 6,746
Research and Forecast on China Insulin Market, 2014-2018
4/15/2014 | published by: Huidian Research
... of China Insulin Market. A survey conducted by Huidian Research shows that China’s insulin market scale approximately registered CNY 11 billion in 2013, of which CNY 7.5 billion achieved in second-generation insulin market and CNY ...  |  read more...
USD 1,800
MediPoint: Bone Grafts and Substitutes - South American Analysis and Market Forecasts
1/31/2014 | published by: GlobalData
... has resulted in a gradual shift towards increased adoption of bone grafts and substitutes (BGS), especially in the US and European markets. In contrast to the general picture in developed countries, autograft bone still represents ...  |  read more...
USD 4,450
MediPoint: Bone Grafts and Substitutes - APAC Analysis and Market Forecasts
1/31/2014 | published by: GlobalData
... resulted in a gradual shift towards increased adoption of bone grafts and substitutes (BGS), especially in the US and European markets. In contrast to the general picture in developed countries, autograft bone still represents the ...  |  read more...
USD 4,450
Plunkett's Health Care Technologies Overview 2014: A Summary Excerpted from Plunkett's Health Care Industry Almanac 2014
11/12/2013 | published by: Plunkett Research, Ltd.
... Research Online Link to our 5-minute video overview of this industry Pages: 76 Statistical Tables Provided: 40 Geographic Focus: Global A condensed market research report excerpted from Plunkett’s Health Care Industry Almanac 2014, including forecasts ...  |  read more...
USD 199.99
Plunkett's Health Care Industry Trends & Statistics 2014: A Summary Version of Plunkett's Health Care Industry Almanac 2014
11/12/2013 | published by: Plunkett Research, Ltd.
... at Plunkett Research Online Link to our 5-minute video overview of this industry Pages: 79 Statistical Tables Provided: 40 Geographic Focus: Global A condensed market research report excerpted from Plunkett’s Health Care Industry Almanac 2014, ...  |  read more...
USD 199.99
Capitalizing on Opportunities in Cord Blood Industry Growth (2013 Version)
11/1/2013 | published by: BioInformant Worldwide, L.L.C.
... as of 2005, and now there are 485 worldwide. Cord blood banks now exist within 98 different countries around the world. That is a 21-fold increase (2,100%) in the companies involved in the industry, in ...  |  read more...
USD 3,995
High Throughput Screening (HTS) Market by Technology (Cell Based, Ultra High Throughput Screening (uHTS), Label Free, Bioinformatics), by Apllications (Target Identification, Primary Screening, Toxicology, Stem Cell) & by End Users (Pharmaceutical Industr
2/4/2014 | published by: MarketsandMarkets
... CRO) - Forecast to 2018 “Technological Advancements and Flourishing Outsourcing Industry Likely to Propel the Growth of the Global High Throughput Screening (HTS) Market” In this report, the global high throughput screening (HTS) market has ...  |  read more...
USD 4,650
Neural Control Trends
1/1/2014 | published by: Global Industry Analysts
... the prospective application areas. In addition, the report also expounds the drawbacks of cyborg insects. Neural control, also known as neural interaction or neural interfacing, is touted to emerge as a revolutionary technology and a ...  |  read more...
USD 950
< prev 1    3  4